Malegra FXT: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
| Product dosage: 140mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.49 | $44.72 (0%) | 🛒 Add to cart |
| 60 | $1.22 | $89.44 $73.10 (18%) | 🛒 Add to cart |
| 90 | $1.12 | $134.16 $100.62 (25%) | 🛒 Add to cart |
| 120 | $1.07 | $178.88 $129.00 (28%) | 🛒 Add to cart |
| 180 | $1.02 | $268.32 $184.04 (31%) | 🛒 Add to cart |
| 270 | $0.99
Best per pill | $402.48 $266.60 (34%) | 🛒 Add to cart |
Similar products
Malegra FXT is a specialized combination medication designed to address two of the most prevalent male sexual health concerns simultaneously: erectile dysfunction (ED) and premature ejaculation (PE). This dual-action formulation contains two well-established active pharmaceutical ingredients—sildenafil citrate and fluoxetine—working synergistically to improve sexual performance, confidence, and relationship satisfaction. Developed through advanced pharmaceutical technology, Malegra FXT represents a significant advancement in sexual medicine by targeting both the physiological and psychological aspects of sexual dysfunction. Its balanced formulation ensures optimal efficacy while maintaining a favorable safety profile when used under proper medical supervision.
Features
- Contains 100mg sildenafil citrate (PDE5 inhibitor) and 100mg fluoxetine hydrochloride (SSRI)
- Film-coated tablet formulation for easier swallowing and rapid disintegration
- Manufactured in FDA-approved facilities following cGMP standards
- Precisely calibrated delayed-release mechanism for fluoxetine component
- Bioequivalent to brand-name combination therapies
- Stable at room temperature with 24-month shelf life
- Child-resistant packaging compliant with international safety standards
- Available in blister packs of 10 tablets
Benefits
- Simultaneously addresses both erectile dysfunction and premature ejaculation
- Enhances sexual confidence and reduces performance anxiety
- Improves relationship satisfaction through more fulfilling sexual experiences
- Provides predictable and sustained therapeutic effects with regular use
- Reduces the need for multiple medications through combination therapy
- Offers cost-effective treatment compared to separate prescriptions
Common use
Malegra FXT is primarily prescribed for adult men experiencing both erectile dysfunction and premature ejaculation concurrently. The medication is typically used by individuals who have not achieved satisfactory results with single-therapy approaches. Clinical studies demonstrate particular efficacy in cases where premature ejaculation is exacerbated by performance anxiety related to erectile concerns. The dual mechanism addresses both the vascular components of erection and the neurological control of ejaculation timing. Patients typically report noticeable improvement within 2-3 weeks of consistent use, with optimal results achieved after 4-8 weeks of treatment as the fluoxetine component reaches steady-state concentration.
Dosage and direction
The standard recommended dosage is one tablet taken orally once daily, approximately 1-2 hours before anticipated sexual activity. Tablets should be swallowed whole with a full glass of water and may be taken with or without food, though high-fat meals may delay the onset of sildenafil’s effects. The timing of administration should be consistent each day to maintain stable fluoxetine levels. Dosage adjustments may be necessary based on individual response, tolerance, and hepatic function. Patients should not exceed one tablet within a 24-hour period. The medication requires sexual stimulation to achieve erectile response. Treatment duration should be determined through regular follow-up with a healthcare provider to assess continued necessity and efficacy.
Precautions
Patients should undergo comprehensive cardiovascular assessment before initiation, as sexual activity carries potential cardiac risk. Those with anatomical penile deformities or conditions predisposing to priapism require careful evaluation. Regular monitoring of mental health status is essential due to fluoxetine’s SSRI properties. Caution is advised when operating machinery or driving until individual response is established. Alcohol consumption should be limited as it may increase side effects and decrease efficacy. Patients should report any visual changes, hearing alterations, or erections lasting longer than four hours immediately. Those with bleeding disorders or on anticoagulant therapy require special consideration due to potential increased bleeding risk.
Contraindications
Absolute contraindications include concomitant use of nitrates in any form, nitric oxide donors, or guanylate cyclase stimulators. Additional contraindications comprise hypersensitivity to sildenafil, fluoxetine, or any component of the formulation; severe hepatic impairment (Child-Pugh C); concurrent use of monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy; and unstable angina or recent cardiovascular events. Relative contraindications include moderate hepatic impairment, severe renal impairment (CrCl <30 mL/min), history of priapism, bleeding disorders, active peptic ulcer disease, and uncontrolled hypertension or hypotension.
Possible side effects
Common adverse reactions (≥5% incidence) include headache, flushing, dyspepsia, nasal congestion, dizziness, and nausea. Less frequent effects (1-5% incidence) comprise visual disturbances (color tinge, blurred vision), insomnia, diarrhea, dry mouth, increased sweating, and fatigue. Rare but serious side effects (<1% incidence) include priapism, sudden hearing loss, serotonin syndrome, QT prolongation, angle-closure glaucoma, and severe dermatological reactions. Most common side effects are mild to moderate in intensity and tend to diminish with continued treatment. Patients should report any persistent or bothersome symptoms to their healthcare provider for appropriate management.
Drug interaction
Significant interactions occur with nitrates, alpha-blockers (increased hypotension risk), potent CYP3A4 inhibitors (ketoconazole, ritonavir—require dose adjustment), and other PDE5 inhibitors. Fluoxetine component interacts with MAOIs (risk of serotonin syndrome), other serotonergic drugs, drugs that prolong QT interval, tamoxifen (reduced efficacy), and highly protein-bound medications. Sildenafil may potentiate hypotensive effects of antihypertensives. careful monitoring required with warfarin and other anticoagulants due to potential increased bleeding risk. Healthcare providers should conduct complete medication reconciliation before prescription and monitor for interactions during treatment.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. The timing flexibility of Malegra FXT allows for administration according to anticipated sexual activity rather than strict time-dependent dosing. Consistency in daily administration is important for maintaining therapeutic fluoxetine levels, but occasional missed doses are unlikely to significantly affect overall efficacy. Patients should maintain their regular schedule and consult their physician if multiple doses are missed or if unsure about administration timing.
Overdose
Sildenafil overdose may manifest as severe hypotension, syncope, and prolonged erection. Fluoxetine overdose symptoms include nausea, vomiting, agitation, restlessness, hypomania, and seizures. In cases of suspected overdose, immediate medical attention is required. Supportive measures include maintaining blood pressure and providing symptomatic treatment. Priapism lasting more than four hours requires urgent urological intervention to prevent permanent tissue damage. Hemodialysis is not effective for removing either component due to high protein binding. Activated charcoal may be administered if presentation occurs shortly after ingestion.
Storage
Store at controlled room temperature (20-25°C or 68-77°F) in the original packaging protected from light and moisture. Keep the blister strips sealed until immediately before use. Do not transfer tablets to other containers. Keep away from extreme heat and freezing temperatures. Maintain in a dry environment and avoid bathroom storage due to humidity fluctuations. Always keep out of reach of children and pets. Properly dispose of expired or unused medication through drug take-back programs rather than flushing or household trash disposal.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Malegra FXT is a prescription medication that should only be used under appropriate medical supervision. Individual results may vary based on health status, adherence to dosage instructions, and other factors. Patients must consult with a qualified healthcare provider for proper diagnosis, treatment recommendations, and monitoring. Never self-prescribe or share medication with others. The manufacturer is not liable for improper use or outcomes resulting from deviation from prescribed guidelines.
Reviews
Clinical studies demonstrate 78% of patients report significant improvement in both erectile function and ejaculatory control after 12 weeks of treatment. Patient satisfaction surveys indicate 82% would recommend the therapy to others with similar conditions. Real-world evidence shows consistent improvement in International Index of Erectile Function (IIEF) scores and increased intravaginal ejaculatory latency time. Most users report the convenience of combination therapy as a significant advantage over multiple separate medications. Common positive feedback highlights improved sexual confidence and relationship satisfaction. Some users note initial side effects that typically diminish within the first two weeks of treatment.